1. Department of Hematology and Oncology, Shenzhen Children’s Hospital, Shenzhen, China;
2. Hemophilia Treatment Centre, Shandong Blood Centre, Jinan, China;
3. Department of Hematology, Peking Union Medical College Hospital, Beijing, China;
4. Hematology/Oncology Centre, Beijing Children’s Hospital, Capital Medical University, Beijing, China;
5. Department of Hematology, Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology (HUST), Hankou, Wuhan, China;
6. Department of Hematology, The Children’s Hospital, Zhengjiang University School of Medicine, Hangzhou, China;
7. Department of Hematology, Nan fang Hospital, Southern Medical University, Guangzhou, China;
8. Thrombosis and Hemostasis Centre, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China;
9. Department of Hematology, Chengdu Women & Children’s Central Hospital, Chengdu, China;
10. Department of Hematology, Nanjing Drum Tower Hospital, Nanjing University Medical School, Nanjing, China;
11. Department of Hematology, Dalian Municipal Central Hospital, Dalian Medical University, Dalian, China;
12. Department of Hematology, Northern Jiangsu People’s Hospital, Clinical Medical School of Yangzhou University, Yangzhou, China;
13. Bayer HealthCare Pharmaceuticals Inc., Beijing, China